The effect of the dihydropyridine nimodipine was studied on the resting and K + -evoked release of pH]acetylcholine (ACh) and r3H]5-hydroxytryptamine (5HT) from postmortem human cerebral arteries. Nimo dipine, at a concentration of 30 fLM, significantly reduced the K + -evoked release of [3H]ACh from anterior and middle cerebral arteries by 36 and 70%, respectively, and the K + -evoked release of [3HJ5HT from basilar and
Cerebral arteries receive a dense innervation of peptide and nonpeptide systems (Larsson et aI., 1976; Chan Palay, 1977; Owman and Edvinsson, 1978; Kontos, 1981; Edvinsson, 1982; Edvinsson et aI., 1983; Yamamoto et aI., 1983) . Ho wever, their density and distribution show some variation be tween species (Bevan, 1984) . There are also marked species differences in cerebrovascular anatomy (Du Boulay and Verity, 1973) . To investigate the mech anism of action of drugs used in the treatment of cerebrovascular diseases, postmortem human ce rebral arteries are therefore the most appropriate arteries to use. These preparations are viable since they retain their ability to respond to depolarising stimuli. Both vasomotor effects and release of transmitter from nerve terminals and varicosities retained in the preparation have been detected. In this study, we have examined the effect of nimodi pine, a dihydropyridine, which has been used in the middle cerebral arteries by 55 and 66%. respectively. The mode of action of nimodipine is interpreted in terms of a specific effect on the depolarisation-induced calcium cur rent occurring in neuronal elements present in these prep arations but absent from brain. Key Words: Acetylcho line-Dihydropyridines-Human cerebral arteries-5-Hydroxytryptamine-Neurotransmitter release-Ni modipine.
treatment of stroke, vasospasm, subarachnoid haem orrhage, and migraine, on the depolarisation-in duced release of 5-hydroxytryptamine (5HT) and acetylcholine (ACh) from human postmortem ce rebral arteries. The selective action of nimodipine on cerebral arteries compared with peripheral ves sels makes it suitable for these treatment applica tions. Dihydropyridines are known to antagonise the voltage-sensitive calcium-dependent contrac tion of arteries (Towart, 1981) , but it is not known whether these agents also have a presynaptic action and are able to modify calcium-dependent trans mitter release. The depolarisation-induced release of neurotransmitters from isolated synaptosomes or presynaptic terminals present in tissue slices is known to be dependent on the presence of calcium (de Belleroche and Bradford, 1973; de Belleroche, 1982) . It is of importance in understanding the ther apeutic action of nimodipine to know whether it is likely to affect calcium-dependent processes at both pre-and postsynaptic sites.
METHODS
Human cerebral arteries were taken postmortem. The time elapsing between death and use of the arteries varied between 30 and 96 h. Age range was 42-86 years, with 14 men and 6 women. The arteries were identified and dissected into longitudinal strips and incubated in Krebs bicarbonate medium of the following composition (mM): NaCI, 118; KCI, 4.7; MgS04 • 7HP, 1.2; NaHC01, 25; KH2P04, l.2; CaCI2, 0.25 or 2.5 as indicated; glucose, 1l.1; pH 7.4, gassed with 95% 0,:5% CO,. Tissue was preincubated at 37°C with eithe-r 0.065 �M [methyl-3H]choline chloride (77 Ci/mmol; Amersham Interna tional) or 0.31 f-lM [3H]5HT (16.2 Ci/mmol; Amersham International) for 30 or 10 min, respectively. Low con centrations of isotope were used to ensure specific uptake by high-affinity transport systems. Pargyline (I mM) and ascorbate (2 mM) were included in the incubation me dium for the studies using [3HJ5HT. The tissue was then transferred to a Perspex block containing four chambers and superfused with Krebs-bicarbonate medium at a rate of 1 ml min � 1 for another 30 min. After this initial period, serial samples [2- ( lection periods] were collected. Pulses of 53.5 mM KCl were applied as a depolarising stimulus (Na + was not omitted). At the end of the superfusion period, tissue was solubilised in soluene (Packard Instruments Co.). The tri tium content of the superfusate and tissue samples was analysed by liquid scintillation counting. Efflux of tritium is expressed as fractional release min -I. i.e., the amount of release in each incubation period as a percentage of the total remaining at the end of that incubation period divided by the time of incubation. A detailed description and characterisation of the method have been published elsewhere (de Belleroche and Neal, 1982 ). An inhibitor of acetylcholinesterase was not included in experiments using [3H]choline. However, when an inhibitor is present. the predominant isotopically labelled species released in response to K + stimulation is [3HjACh. Similarly, the predominant species released by K + is [3Hj5HT when used under these experimental conditions. Aquasol 2 (New England Nuclear, Southampton) was used as the scintillant. The tissue obtained from each region was di vided into two portions, one being the control, and the other portion was tested with nimodipine. Nimodipine (Bayer UK) was dissolved in dimethylsulfoxide (DMSO) to give a 30 mM solution. This was further diluted with Krebs-bicarbonate medium to give 30 f-lM nimodipine. A parallel vehicle solution was similarly made up containing 100 f-ll DMSO in 100 ml Krebs-bicarbonate medium. Tissue was superfused during the collection period for 8 min in the absence of drug and then switched to super fusion with either vehicle or nimodipine-containing me dium for the remainder of the incubation. K + was applied in vehicle or nimodipine medium, respectively.
Tissue slices of male CFY rat (250 g body weight) ce rebral cortex were also used to study the effect of ni modipine. The incubation procedure was similar to that described above for incubation of cerebral arteries, ex cept that 34 mM KCl was used to stimulate transmitter release.
Statistical analysis was carried out by Student's t test (paired).
RESULTS
Portmortem artery preparations taken 30-96 h after death were able to accumulate [3H]choline and [3H]SHT and respond to an elevated K + medium by an increased release of tritium. Cerebral arteries from the same subjects and from other subjects at a similar time after death were also used in a parallel investigation into vasomotor responses (Eccles and Leathard, 1985) . Spiral strips of cerebral artery taken 24-96 h after death contracted in response to a range of concentrations of SHT (2.6 x 10-9-5.2 x 1O�6 M) and noradrenaline (2.9 x 1O�9-S.9 x 10-6 M). Release of [3H]ACh by 53.S mM K + was increased up to 10 times above the resting level of release in the presence of 2.5 mM Ca2+ in most cerebral arteries, as illustrated in Fig. 1 for anterior, middle, and posterior cerebral and posterior inferior cerebellar arteries. Since the dihydropyridines are thought to antagonise the voltage-sensitive calcium dependent process, a low calcium concentration (0.25 mM) was used to study the effect of nimodi pine. An inhibitory effect on calcium-dependent re lease would be more effectively overcome by low exogenous calcium. In the presence of 0.25 mM cal cium, a significant increase in release of both [3H]ACh and [3H]5HT was obtained in response to K +, but the magnitude of the effect was consider ably attenuated, increasing I.S-2.5 times above the resting level of release.
The presence of nimodipine (30 J-LM) caused a significant inhibition of the K + -evoked release of t'H]ACh in the anterior and middle cerebral arteries of 36 and 70%. respectively (Fig. 2, left) . Lower concentrations of nimodipine, 0.1, 1.0, and 10 J-LM. did not produce a significant effect on release. The release of [3HjACh from basilar artery was unaf fected by nimodipine. The release of [3H]5HT was, on the other hand. significantly reduced by nimo dipine (30 J-LM) in basilar and posterior cerebral ar teries by 55 and 66%, respectively, but not in an terior and middle cerebral arteries (Fig. 2, right) .
Comparable effects of nimodipine (30 J-LM) on the release of [3H]ACh and [3H]5HT from tissue slices of rat cerebral cortex did not occur using the same conditions as for the arteries. Nimodipine (up to 30 J-LM) did not significantly alter the resting or 34 mM K + -evoked release of [3H]SHT from tissue slices of rat cerebral cortex. Release of [3HjACh was signif icantly reduced by nimodipine (30 J-LM) (p < 0.05) from 2.12 ± 0.11 (n = 8) to 1.86 ± 0 . 11 (n = 8) in the presence of 1.2 mM Ca� + (values are means ± SEM fractional release min � I), which is a much smaller reduction (12%) than that seen in middle and posterior cerebral arteries.
DISCUSSION
The presence of 5HT-containing nerve fibres in mammalian cerebral arteries has been demon strated from immunocytochemical studies (Griffith et aI., 1982; Griffith and Burnstock, 1983) matography (Edvinsson et aI. , 1984) and by the presence of uptake systems for 5HT (Chan Palay, 1976 Palay, , 1977 Napoleone et aI., 1982; Edvinsson et aI., 1984) . 5HT has a potent vasoconstrictor action on cerebral vessels (Edvinsson et aI., 1978) , and in this study it has been shown to be released from human cerebral vessels in response to depolarising concentrations of K + . A cholinergic innervation of cerebral vessels is also indicated by the localisation of choline acetyltransferase (ChAT) and presence , 1979) . The action of ACh in these vessels is to cause vasodilation, which is likely to be mediated by the muscarinic receptors present (Edvinsson et aI., 1977; Lee et aI., 1978; Bevan et aI., 1982) . The likely role of ACh as a transmitter specifically in human cerebral vessels is supported from the present studies, where depolarisation in duced a release of ACh up to 10 times greater than the basal release. Although degenerative changes will occur postmortem, a significant response is still retained 30-90 h after death. The nature of this re sponse is similar to that found in fresh canine ce rebral vessels, where a clear K + stimulation of [3H]ACh release is seen in middle cerebral vessels (I. D. Porter et aI., in preparation). A much smaller response is induced in canine basilar preparations with K + stimulation, which is similar to that seen in the human basilar preparation and is consistent with the lower levels of ChAT activity found in ca nine vessels from this region compared with ante rior, middle, and posterior cerebral vessels (Flor ence and Bevan, 1979) . At a concentration of 30 f.lM, nimodipine caused a significant inhibition of transmitter release from cerebral arteries. Both [3H]ACh and [3H]5HT re lease were affected, but the cerebral arteries tested were inhibited differentially. The smaller cholin ergic response seen in basilar arteries and lack of effect of nimodipine might reflect a POOll.OI inner vation of this region (as discussed above). Sufficient evidence is not yet available about the regional vari ation of the 5HT innervation to know whether the differential effect of nimodipine on 5HT release re flects regional differences in innervation or a re gion-specific effect of nimodipine. Release of l3H]ACh from anterior and middle cerebral arteries was inhibited by nimodipine, whereas release of [3H]5HT from basilar and posterior cerebral arteries was affected by nimodipine although the anterior and middle cerebral arteries were not. The concen tration of nimodipine necessary to induce a signif icant inhibition of release is considerably higher (two to four orders of magnitude) than that reducing voltage-sensitive calcium channels in smooth muscle and heart. Although brain is one of the richest sources of high-affinity dihydropyridine binding sites (Bellemann et aI., 1982 (Bellemann et aI., , 1983 Peroutka and Allen, 1983) , dihydropyridines show little ability to block voltage-sensitive calcium channels in nerve cells. Depolarisation-induced calcium cur rents measured electrophysiologically or by 45Ca2, or the fluoresence of Ca2 + -sensitive dyes are not affected by dihydropyridines such as nifedipine, ni trendipine, or nimodipine at concentrations up to 10 f.lM lreviewed by Miller and Freedman (1984) ]. Similarly, depolarisation-induced release of nor adrenaline is not affected by concentrations of up to 100 f.lM nicardipine in rabbit ear artery (Kajiwara and Casteels, 1983) , by 3 f.lM nifedipine in basilar artery (Hogestatt et aI., 1982) , by 50 f.lM nifedipine in guinea pig cortex (Ebstein and Daly, 1982) , or by 20 f.lM nitrendipine in rat phrenic nerve (Fairhurst et al., 1983) . Although the concentration of nimo dipine necessary to obtain a significant effect in the present study was greater than that of most of the dihydropyridines used in the above studies, some isolated reports have been obtained in which dihy dropyridines are effective inhibitors of neuronal voltage-sensitive calcium currents, e.g., nicardipine in chick retinal cells and PC12 neuronal cells in cul ture (Takahashi and Ogura, 1983) .
Current evidence indicates that dihydropyridine sensitive sites in neuronal tissues are not linked to calcium movement in the same way as occurs in smooth muscle and peripheral organs. This may be due to the employment of different coupling mech anisms. Dihydropyridine binding sites are abundant in the CNS, and it is possible that a related system exists that requires higher dihydropyridine concen trations for inhibition. This would explain why some preparations or high drug concentrations are able to elicit an inhibition. Nimodipine used thera peutically in treatment of vasospasm or stroke is given by intravenous infusion at a concentration of 2 mg/L (16 f.lM), which may give rise to levels at which an inhibitory effect on transmitter release cannot be precluded.
It is difficult to predict whether the presynaptic action of nimodipine would have a significant mod ulatory effect on the more potent effects seen post synaptically. Tr ansmitter action will depend on the state of muscle tone: 5HT produces vasoconstric tion and dilatation of prostaglandin F 2 u-constricted arteries, whereas ACh causes dilatation. A presyn aptic reduction in 5HT release with nimodipine would serve to accentuate its antagonistic effect on 5HT-induced muscle contraction. Both actions may therefore be relevant to the use of nimodipine in migraine and vasospasm, where 5HT has been im plicated in the aetiology. A similar attenuation of vasodilator responses may occur through modula tion of release.
